Table 2:
Changes in Disease Specific and Generic Health Status after S3-TAVR
| N | Paired Difference vs. Baseline (95% CI) | p-value | |
|---|---|---|---|
| KCCQ Overall Summary | |||
| 30 Days | 1009 | 19.1 (17.7, 20.4) | < 0.001 |
| 1 Year | 907 | 23.1 (21.8, 24.9) | < 0.001 |
| KCCQ Physical Limitations | |||
| 30 Days | 963 | 13.7 (12.2, 15.2) | < 0.001 |
| 1 Year | 854 | 15.1 (13.4, 16.9) | < 0.001 |
| KCCQ Total Symptoms | |||
| 30 Days | 1009 | 16.3 (15.0, 17.7) | < 0.001 |
| 1 Year | 907 | 18.2 (16.0, 19.7) | < 0.001 |
| KCCQ Quality of Life | |||
| 30 Days | 1008 | 26.7 (25.0, 28.3) | < 0.001 |
| 1 Year | 903 | 32.9 (31.0, 34.7) | < 0.001 |
| KCCQ Social Limitation | |||
| 30 Days | 885 | 18.8 (16.7, 21.0) | < 0.001 |
| 1 Year | 779 | 26.6 (24.2, 29.0) | < 0.001 |
| SF-36 Physical Summary | |||
| 30 Days | 991 | 4.8 (4.2, 5.3) | < 0.001 |
| 1 Year | 885 | 5.1 (4.5, 5.8) | < 0.001 |
| SF-36 Mental Summary | |||
| 30 Days | 991 | 3.6 (2.9, 4.3) | < 0.001 |
| 1 Year | 885 | 3.9 (3.1, 4.7) | < 0.001 |
| EQ-5D Utilities | |||
| 30 Days | 1003 | 0.065 (0.054, 0.076) | < 0.001 |
| 1 Year | 902 | 0.050 (0.038, 0.062) | < 0.001 |
Abbreviations: KCCQ – Kansas City Cardiomyopathy Questionnaire